TRES ALCHEMIX
LIVE

Serial Number

79437628

Owner

Tres Alchemix Co., Ltd.

Attorney

Michael A. Geller

Filing Date

Sep 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TRES ALCHEMIX Trademark

Serial Number: 79437628

TRES ALCHEMIX is a trademark filed by Tres Alchemix Co., Ltd. on September 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Tres Alchemix Co., Ltd.

Room 312, Toukan Hakata Dai 5 Building,

Entity Type: 03

Trademark Details

Filing Date

September 3, 2025

Registration Date

Not Registered

Published for Opposition

August 4, 2026

Goods & Services

Downloadable computer programs for use in artificial intelligence-based identification of new therapeutic strategies including novel drug discovery and multimodal data analysis; electronic calculators; computers and their peripherals; computer peripheral apparatus; computer hardware; computer peripheral devices; data processors; calculating machines

Medicines for use in oncology, and for treating cardiovascular diseases, neurology, immunology, and infectious diseases; Pharmaceutical preparations and substances for use in oncology, and for treating cardiovascular diseases, neurology, immunology, and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, and for treating cardiovascular diseases, neurology, immunology, and infectious diseases; gauze for dressings; sanitary napkins; fungicides only for agricultural purposes; fumigants only for agricultural purposes; rodenticides only for agricultural purposes; insect-repellents only for agricultural purposes; insecticides only for agricultural purposes; weedkillers; antiseptics only for agricultural purposes

Artificial intelligence technology consultancy; research in the field of artificial intelligence technology; Providing temporary use of online, non-downloadable computer programs for use in artificial intelligence-based identification of new therapeutic strategies including novel drug discovery and multimodal data analysis on data networks; rental of computers; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; chemical research; medical research; surveying; scientific research;Technological research in the field of artificial intelligence-based identification of new therapeutic strategies including novel drug discovery and multimodal data analysis; Software as a service (SaaS) services featuring software for artificial intelligence-based identification of new therapeutic strategies including novel drug discovery and multimodal data analysis

Management of computerized files; systemization of information into computer databases; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; providing business information; business management; providing assistance in the field of business management; advertising services; advertising and publicity services; data processing services

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 6, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 6, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 14, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 14, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 20, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 1, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 27, 2025 REPR